Orgyne Pharmaceuticals (Opc) Private Limited - Company Profile

It is a pharma enterprise based in Hayathnagar, Telangana, India, established in 2019.
2019 Hayathnagar, Telangana, India Active
Last Updated:
Access Report
About Orgyne Pharmaceuticals (Opc) Private Limited

Orgyne Pharmaceuticals (Opc) Private Limited, Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24230TG2019PTC135766. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.10 M.

Its leadership includes Nayani Jayamma (Member), Poluru Kiran Kumar (Nominee). Past directors included Kurni Haritha, Poluru Kiran Kumar. Its latest AGM occurred on 22 July 2024, with the balance sheet filed on 31 March 2025. It is based at Flat No 102, First Floor, Seven Hills Residency,Plot No 24, Survey 50, 12-1-485/24/7, Road No 1, Dhanalaxmi Nagar, Indraprastha Colony, Bandlaguda, Hayathnagar, Telangana, 500068.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24230TG2019OPC135766

  • Registration Number

    135766

  • Incorporation Date

    28 September 2019

  • Authorized Capital

    ₹1.00 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Hyderabad

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 1.00 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 6 Year, 4 Months
  • Last Filing with ROC 31 Mar 2025
  • Revenue Growth **** 645.28%
  • Profit Growth **** -25.97%
  • Ebitda **** -23.84%
  • Net Worth -140.70%
  • Total Assets **** 99.55%
Company report

Orgyne Pharmaceuticals (Opc) Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Orgyne Pharmaceuticals (Opc) Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Orgyne Pharmaceuticals (Opc) Private Limited?
Current Directors
Name Designation Appointment Date Status
Nayani Jayamma Member 21 Aug 2024 Current
Poluru Kiran Kumar Nominee 21 Aug 2024 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 29 Jan 2025 Past
Pramod Abcsdd Nominee 21 Aug 2024 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Orgyne Pharmaceuticals (Opc).

Orgyne Pharmaceuticals Private Limited, for the financial year ended 2021, experienced significant growth in revenue, with a 645.28% increase. The company also saw a substantial fall in profitability, with a 25.97% decrease in profit. The company's net worth observed a substantial decline by a decrease of 140.7%.

Orgyne Pharmaceuticals (Opc) revenue growth over time
Orgyne Pharmaceuticals (Opc) profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 645.28%
*******
*******
*******
*******
Revenue from Operations
*******
 645.28%
*******
*******
*******
*******
Total Assets
*******
 99.55%
*******
*******
*******
*******
Profit or Loss
*******
 -25.97%
*******
*******
*******
*******
Net Worth
*******
 -140.70%
*******
*******
*******
*******
EBITDA
*******
 -23.84%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Orgyne Pharmaceuticals (Opc)?

In 2021, Orgyne Pharmaceuticals (Opc) had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Orgyne Pharmaceuticals (Opc)?

Unlock and access historical data on people associated with Orgyne Pharmaceuticals (Opc), such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Orgyne Pharmaceuticals (Opc), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Orgyne Pharmaceuticals (Opc)'s trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Orgyne Pharmaceuticals (Opc)
Recent Activity within the Organization
  • Balance Sheet

    The activity Orgyne Pharmaceuticals (Opc) Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Hyderabad. was completed.

  • Director Appointment

    The activity Nayani Jayamma was appointed as a Member was appointed as a Member on 21 Aug 2024 & has been associated with this company since 1 year 6 months . was completed.

  • Director Appointment

    Poluru Kiran Kumar was appointed as a Nominee was appointed as a Nominee on 21 Aug 2024 & has been associated with this company since 1 year 6 months . was recorded as a recent event.

  • Annual General Meeting

    Orgyne Pharmaceuticals (Opc) Private Limited last Annual general meeting of members was held on 22 Jul 2024 as per latest MCA records. was recorded as a recent event.

  • Company Incorporation

    The activity Orgyne Pharmaceuticals (Opc) Private Limited was registered on 28 Sep 2019 with Roc Hyderabad & aged 6 years 4 months as per MCA records. was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Orgyne Pharmaceuticals (Opc) Private Limited?

The CIN of Orgyne Pharmaceuticals (Opc) Private Limited is U24230TG2019OPC135766.

Where is Orgyne Pharmaceuticals (Opc) Private Limited headquartered?

Orgyne Pharmaceuticals (Opc) Private Limited is headquartered at Flat No 102, First Floor, Seven Hills Residency,Plot No 24, Survey 50, 12-1-485/24/7, Road No 1, Dhanalaxmi Nagar, Indraprastha Colony, Bandlaguda, Hayathnagar, Telangana, 500068.

When was Orgyne Pharmaceuticals (Opc) Private Limited incorporated?

Orgyne Pharmaceuticals (Opc) Private Limited was incorporated on 28 September 2019.

Who are the current directors of Orgyne Pharmaceuticals (Opc) Private Limited?

The current directors of Orgyne Pharmaceuticals (Opc) Private Limited are

What is the primary industry of Orgyne Pharmaceuticals (Opc) Private Limited?

The primary industry of Orgyne Pharmaceuticals (Opc) Private Limited is Manufacturing.

Is Orgyne Pharmaceuticals (Opc) Private Limited a listed company?

Orgyne Pharmaceuticals (Opc) Private Limited is unlisted.

What is the capital structure of Orgyne Pharmaceuticals (Opc) Private Limited?

The authorized capital of Orgyne Pharmaceuticals (Opc) Private Limited is ₹1.00 M, and the paid-up capital is ₹0.10 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available